AlzheimerChain Foundation s.r.o.

Introduction of new paradigm where patients are rewarded by sharing their research data would facilitate large scale screening and gathering of big data on prevention

From the manufacturer's own website. Source

AlzheimerChain Foundation s.r.o. develops the TERRAPINO, a digital platform designed to incentivise patients by rewarding them for contributing research data. The system focuses on large-scale screening and the collection of data to support preventive measures related to Alzheimer’s disease.

The TERRAPINO platform is classified as a Class I medical device and is registered in the EU’s eudamed database. The company is based in the Czech Republic.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.